Dengue vaccine study for healthy children ages 2 to 17
This trial tests an experimental dengue vaccine in healthy children and teens to see if it can prevent dengue. It may help protect your child from this mosquito-borne illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 17 years old and generally healthy.
- Your child does not have a weakened immune system, including from HIV, hepatitis B or C, or cancer.
- Your child has never received a dengue vaccine before and will not get one during the study.
- Your child cannot have had steroid medications, blood transfusions, or immune-suppressing treatments within the past month or longer.
- Your child does not have a bleeding disorder or serious long-term illness like uncontrolled diabetes or heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new dengue vaccine in adults aged 40 to 79 to see if it can protect them from dengue fever. If you are generally healthy and willing to follow the study schedule, you may be able to join.
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
This study tests if a two-dose dengue vaccine works better than the standard single dose for children and teens who have never had dengue. It also checks if the vaccine works the same when made at a different factory.
This study tests a dengue vaccine (TDV) in adults aged 45 to 79. It aims to see if the vaccine is safe and effective, even for people with common health conditions like diabetes or high blood pressure.
This study looks at how the dengue vaccine works in people with and without past exposure to dengue or similar viruses like yellow fever or Zika. Volunteers receiving the dengue vaccine will give blood samples to help researchers understand the immune response.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.